Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $15.7000 (-2.18%) ($15.6900 - $16.1900) on Mon. Oct. 14, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.7% (three month average) | RSI | 47 | Latest Price | $15.7000(-2.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.1% a day on average for past five trading days. | Weekly Trend | HALO advances 0.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(54%) IBB(53%) IWM(49%) XBI(49%) IWC(48%) | Factors Impacting HALO price | HALO will decline at least -0.85% in a week (0% probabilities). VIXM(-37%) VXX(-19%) UUP(-6%) TLT(-4%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.85% (StdDev 1.7%) | Hourly BBV | 0 () | Intraday Trend | -2.2% | | | |
|
Resistance Level | $15.79 | 5 Day Moving Average | $15.69(0.06%) | 10 Day Moving Average | $15.65(0.32%) | 20 Day Moving Average | $15.79(-0.57%) | To recent high | -8.5% | To recent low | 3.3% | Market Cap | $2.146b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |